Table 2 Comparisons of clinical courses after therapy in macrolide-resistantMycoplasma pneumoniae pneumonia
DOX group | ATD group | AZI group | p-value* | |
|---|---|---|---|---|
n = 17 | n = 58 | n = 31 | ||
Hospitalization duration(d) | 6 (5, 7) | 8 (7, 9) | 8 (7, 10) | 0.000 |
Fever duration after treatment(d) | 2 (0, 4) | 4 (3, 5) | 3 (3, 4) | 0.020 |
Defervescence within 48 h (n, %) | 8/15 (53%) | 10/55 (18%) | 1/31 (3%) | 0.000 |
Chest X-ray improvement (n, %) | 15 (88%) | 30 (52%) | 12 (39%) | 0.004 |
Glucocorticoid (n,%) | 1 (6%) | 16 (28%) | 14 (45%) | 0.015 |